MPM BioVentures 2014, L.P.

Holdings History for Werewolf Therapeutics, Inc. - Common Stock (HOWL)

Symbol: HOWL on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Shares Owned: 3,368,670 shares
Security Ownership %: 6.9%

ANSBERT GADICKE ownership in Werewolf Therapeutics, Inc. Common Stock (HOWL)

16 Jan 2026 - ANSBERT GADICKE has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,368,670 shares of Werewolf Therapeutics, Inc. Common Stock (HOWL). This represents 6.9% ownership of the company. In their previous filing dated 29 Dec 2025, MPM BioVentures 2014, L.P. had reported owning 3,977,612 shares, indicating a decrease of +15%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
ANSBERT GADICKE	6.9%	-16%	$2,136,074	3,368,670	-608,942	-15%	$0.63	13D/A	14 Jan 2026	16 Jan 2026, 17:36
ANSBERT GADICKE	8.2%	-18%	$3,619,627	3,977,612	-889,729	-18%	$0.91	13D/A	22 Dec 2025	29 Dec 2025, 18:59
ANSBERT GADICKE	10%	-12%	$4,526,627	4,867,341	-614,198	-11%	$0.93	13D/A	01 Dec 2025	03 Dec 2025, 19:04
ANSBERT GADICKE	11%	-16%	$7,674,155	5,481,539	-666,071	-11%	$1.40	13D/A	13 Nov 2025	17 Nov 2025, 20:00
ANSBERT GADICKE	13%		$12,110,792	6,147,610			$1.97	13D/A	31 Oct 2025	04 Nov 2025, 18:33